X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (338) 338
index medicus (299) 299
male (281) 281
humans (245) 245
female (169) 169
rats (155) 155
receptors, adrenergic, beta-3 - metabolism (120) 120
mice (110) 110
adrenergic beta-agonists - pharmacology (104) 104
urinary bladder, overactive - drug therapy (88) 88
adrenergic beta-3 receptor agonists - pharmacology (79) 79
adrenergic beta-3 receptor agonists (76) 76
adrenergic beta-3 receptor agonists - therapeutic use (71) 71
mirabegron (71) 71
obesity (70) 70
overactive bladder (68) 68
middle aged (67) 67
pharmacology & pharmacy (67) 67
aged (58) 58
dose-response relationship, drug (55) 55
mice, inbred c57bl (54) 54
rats, sprague-dawley (54) 54
rats, wistar (52) 52
receptors, adrenergic, beta-3 - genetics (52) 52
acetanilides - therapeutic use (50) 50
adrenergic beta-3 receptor agonists - administration & dosage (50) 50
thiazoles - therapeutic use (50) 50
adult (49) 49
dioxoles - pharmacology (48) 48
urology & nephrology (46) 46
adrenergic beta-3 receptor agonists - adverse effects (45) 45
obesity - metabolism (43) 43
receptors, adrenergic, beta-3 (43) 43
adrenergic receptors (42) 42
ethanolamines - pharmacology (42) 42
neurosciences (42) 42
acetanilides - adverse effects (39) 39
adipose tissue, brown - metabolism (39) 39
thiazoles - adverse effects (39) 39
adrenergic beta-antagonists - pharmacology (38) 38
disease models, animal (38) 38
rodents (38) 38
urinary incontinence (38) 38
endocrinology & metabolism (37) 37
treatment outcome (37) 37
expression (36) 36
muscarinic antagonists - therapeutic use (36) 36
uncoupling protein 1 (36) 36
urinary bladder - drug effects (36) 36
adipose tissue - metabolism (35) 35
thermogenesis (35) 35
time factors (35) 35
administration, oral (34) 34
cell biology (34) 34
thiazoles - administration & dosage (34) 34
acetanilides - administration & dosage (33) 33
analysis (31) 31
beta-adrenoceptor agonist (31) 31
efficacy (31) 31
mice, knockout (31) 31
receptors, adrenergic, beta-3 - drug effects (31) 31
adipocytes (30) 30
article (30) 30
nitric oxide (30) 30
receptors, adrenergic, beta-3 - physiology (30) 30
adrenoceptor (29) 29
biomedicine (29) 29
isoproterenol - pharmacology (29) 29
pharmacology/toxicology (29) 29
receptors, adrenergic, beta - drug effects (29) 29
rna, messenger - metabolism (29) 29
safety (29) 29
beta-adrenoceptor (28) 28
double-blind (28) 28
medicine & public health (28) 28
physiology (28) 28
thiazoles - pharmacology (28) 28
acetanilides - pharmacology (27) 27
insulin - blood (27) 27
physiological aspects (27) 27
propanolamines - pharmacology (27) 27
care and treatment (26) 26
urinary bladder, overactive - physiopathology (26) 26
insulin resistance (25) 25
receptors, adrenergic, beta - metabolism (25) 25
urology (25) 25
activation (24) 24
adipose tissue - drug effects (24) 24
adrenergic beta-3 receptor antagonists - pharmacology (24) 24
brown adipose-tissue (24) 24
in vitro techniques (24) 24
metabolism (24) 24
research article (24) 24
signal transduction (24) 24
adipose tissue (23) 23
adipose tissue, brown - drug effects (23) 23
adrenergic beta-agonists - administration & dosage (23) 23
biochemistry & molecular biology (23) 23
blood glucose - metabolism (23) 23
heart (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 3, pp. 389 - 399
Abstract Background Persistence with antimuscarinic therapy in overactive bladder (OAB) is poor, but may be different for mirabegron, a β3 -adrenoceptor... 
Urology | Adherence | Persistence | Antimuscarinics | Overactive bladder | Observational | Mirabegron | BETA-ADRENOCEPTOR AGONIST | MEDICATION | EFFICACY | SAFETY | TERMINOLOGY | SYMPTOMS | WOMEN | TOLERABILITY | UROLOGY & NEPHROLOGY | EXPERIENCE | URINARY-INCONTINENCE | Acetanilides - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Thiazoles - administration & dosage | Adrenergic beta-3 Receptor Agonists - adverse effects | Thiazoles - adverse effects | Young Adult | Urinary Bladder, Overactive - drug therapy | Urological Agents - adverse effects | Time Factors | Urinary Bladder, Overactive - physiopathology | Aged, 80 and over | Urological Agents - administration & dosage | Adult | Female | Retrospective Studies | Acetanilides - adverse effects | Odds Ratio | Adrenergic beta-3 Receptor Agonists - administration & dosage | Databases, Factual | Urinary Bladder, Overactive - diagnosis | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | United Kingdom | Chi-Square Distribution | Muscarinic Antagonists - administration & dosage | Medication Adherence | Aged | Longitudinal Studies | Urinary incontinence | Medicine, Experimental | Complications and side effects | Medical research | Care and treatment | Patient compliance
Journal Article
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 11/2014, Volume 64, Issue 5, pp. 407 - 411
Journal Article
Journal Article
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 3/2013, Volume 386, Issue 3, pp. 247 - 253
Journal Article
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 11/2014, Volume 742, pp. 75 - 80
Hyperlipidemia can be harmful to the lung and β -adrenoceptor agonist can improve lipid metabolism disorders. In this study, we aim to investigate the effects... 
Beta3 adrenoceptor | Angiotensin receptor | Interaction | Apolipoprotein E knockout | SUBTYPES | ALVEOLAR FLUID CLEARANCE | RATS | BETA-ADRENOCEPTOR | ADRENERGIC-RECEPTOR | SIGNAL-TRANSDUCTION | PATHWAY | APOE-DEFICIENT MICE | PHARMACOLOGY & PHARMACY | BLOCKADE | EXPRESSION | Receptors, Angiotensin - metabolism | Hyperlipidemias - genetics | Apolipoproteins E - deficiency | Cholesterol - blood | Male | Adrenergic beta-3 Receptor Agonists - pharmacology | RNA, Messenger - metabolism | Receptor, Angiotensin, Type 1 - genetics | Aging - genetics | Receptors, Adrenergic, beta-3 - genetics | Receptors, Adrenergic - genetics | Cholesterol, LDL - blood | Lung - metabolism | Adrenergic beta-3 Receptor Agonists - administration & dosage | Receptor, Angiotensin, Type 2 - genetics | Hyperlipidemias - metabolism | Receptors, Adrenergic - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Receptors, Adrenergic, beta-3 - metabolism | Receptors, Angiotensin - genetics | Mice, Knockout | Animals | Receptor, Angiotensin, Type 2 - metabolism | Adrenergic beta-3 Receptor Antagonists - pharmacology | Apolipoproteins E - genetics | Lung - drug effects | Receptor, Angiotensin, Type 1 - metabolism | Triglycerides - blood | Mice | Aging - metabolism | Physiological aspects | Triglycerides | RNA | Low density lipoproteins | Analysis | Angiotensin
Journal Article